Last 2.12 INR
Change Today +0.10 / 4.95%
Volume 900.0
SBIL On Other Exchanges
Symbol
Exchange
Mumbai
As of 5:00 AM 12/19/14 All times are local (Market data is delayed by at least 15 minutes).

saamya biotech india ltd (SBIL) Snapshot

Open
1.99
Previous Close
2.02
Day High
2.12
Day Low
1.99
52 Week High
09/25/14 - 6.25
52 Week Low
04/16/14 - 0.98
Market Cap
52.8M
Average Volume 10 Days
8.1K
EPS TTM
0.04
Shares Outstanding
24.9M
EX-Date
--
P/E TM
55.5x
Dividend
--
Dividend Yield
--
Current Stock Chart for SAAMYA BIOTECH INDIA LTD (SBIL)

Related News

No related news articles were found.

saamya biotech india ltd (SBIL) Related Businessweek News

No Related Businessweek News Found

saamya biotech india ltd (SBIL) Details

Saamya Biotech (India) Limited, a biotechnology company, focuses on the manufacture and marketing of biopharmaceuticals and recombinant protein products. The company was incorporated in 2002 and is based in Hyderabad, India.

Founded in 2002

saamya biotech india ltd (SBIL) Top Compensated Officers

Managing Director, Executive Director, Member...
Total Annual Compensation: 225.0K
Chairman and Joint Managing Director
Total Annual Compensation: 225.0K
Compensation as of Fiscal Year 2014.

saamya biotech india ltd (SBIL) Key Developments

Saamya Biotech (India) Limited Announces the appointment of Mr. Kishan Kumar Srishankar Jha as Additional Director

Saamya Biotech (India) Limited announced that Mr. Kishan Kumar Srishankar Jha, has been appointed as additional director of the company with effect from November 18, 2014.

Saamya Biotech (India) Limited Reports Unaudited Standalone Earnings Results for Second Quarter and Six Months Ended September 30, 2014

Saamya Biotech (India) Limited reported unaudited standalone earnings results for second quarter and six months ended September 30, 2014. For the quarter, the company reported loss from operations before other income, finance cost and exceptional items of INR 861,413 compared to INR 1,179,435 a year ago. Loss from ordinary activities before tax was INR 871,656 compared to INR 1,215,628 a year ago. Net loss for the period was INR 871,656 or INR 0.04 per basic and diluted share compared to INR 1,215,628 or INR 0.05 per basic and diluted share for the same period a year ago. For the six months, the company reported loss from operations before other income, finance cost and exceptional items of INR 1,763,700 compared to INR 2,398,680 a year ago. Loss from ordinary activities before tax was INR 1,830,962 compared to INR 2,483,778 a year ago. Net loss for the period was INR 1,830,962 or INR 0.07 per basic and diluted share compared to INR 2,479,248 or INR 0.10 per basic and diluted share for the same period a year ago.

Saamya Biotech (India) Limited to Report Q3, 2014 Results on Nov 14, 2014

Saamya Biotech (India) Limited announced that they will report Q3, 2014 results on Nov 14, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SBIL:IN 2.12 INR +0.10

SBIL Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for SBIL.
View Industry Companies
 

Industry Analysis

SBIL

Industry Average

Valuation SBIL Industry Range
Price/Earnings 31.7x
Price/Sales 0.3x
Price/Book 0.1x
Price/Cash Flow 14.6x
TEV/Sales 0.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SAAMYA BIOTECH INDIA LTD, please visit www.saamyabiotech.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.